{{Rsnum
|rsid=2395
|Gene=MARK4
|Chromosome=19
|position=45303351
|Orientation=plus
|GMAF=0.41
|Gene_s=MARK4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.6 | 49.2 | 46.2
| HCB | 50.0 | 45.5 | 4.5
| JPT | 61.4 | 29.5 | 9.1
| YRI | 3.2 | 30.6 | 66.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 50.0 | 45.5 | 4.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22506312
|Title=Investigation of two Wnt signalling pathway single nucleotide polymorphisms in a breast cancer-affected Australian population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}